NCT02798289View on ClinicalTrials.gov

Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Dry Eye SyndromeKeratoconjunctivitis Sicca
Interventions
DEVICE

Oculeve Intranasal Neurostimulator

Neurostimulation device

Trial Locations (2)

90701

Sall Research Medical Center, Artesia

92663

Aesthetic Eyecare Institute, Newport Beach

Sponsors

Lead Sponsor

Oculeve, Inc.
All Listed Sponsors
lead

Oculeve, Inc.

INDUSTRY